Name patient supply
Special medications for rare diseases — for patients worldwide
Today, the exact cause for many rare diseases remains unknown. While some are traceable to single-gene mutations, environmental factors play significant roles. These diseases need special medications — what the WHO terms orphan drugs, special drugs or unlicensed drugs.
Finding these medications is often impossible in the patient's home market — limited local availability, adequacy of treatments and import paperwork. GNH USA has taken the lead in fulfilling this unmet need, anywhere in the world.
What we do
WHO GDP-certified access to special medications
WHO GDP-certified
One of the few GDP-certified distributors operating worldwide.
Sourced from 60+ countries
Upstream sourcing to serve regulator-approved markets worldwide.
Patient-first
Designed around patients, caregivers and prescribers.
Where we supply
Named-patient & orphan-drug supply by market
United Kingdom
Unlicensed & Specials medicines, handled under MHRA requirements.
Australia
Supply under the TGA Special Access Scheme and Authorised Prescriber routes.
South Korea
Orphan & named-patient access, subject to MFDS and KODA requirements.
China
Orphan & named-patient drug supply, subject to NMPA requirements.
Orphan drug supply
Rare-disease medicines sourced from regulator-approved markets worldwide.
Managed access programs
Expanded-access and compassionate-use programs for sponsors.
The process
How named-patient supply works
- Step 01
Request medicine
Patients, caregivers or physicians request the medicine.
- Step 02
Verification
GNH processes and verifies the prescription.
- Step 03
Sourcing
We search and identify the best source for the medicine.
- Step 04
Procurement
Procurement by the fastest GDP-compliant route.
- Step 05
Shipping
After internal QA, the medicine ships via validated lanes.
Apply online
Submit your doctor's prescription
We'll validate the prescription and get back to you with availability and timing.
FAQ
Frequently asked questions
What is named-patient supply?
Named-patient supply is the legal, compliant supply of an unlicensed or hard-to-find medicine for a specific, named individual patient — usually against a doctor's prescription — when the medicine is not available in the patient's home market.
What kinds of medicines can you supply on a named-patient basis?
We supply orphan drugs, special drugs and unlicensed medicines for rare diseases, sourced from regulator-approved markets worldwide.
Is a prescription required?
Yes. GNH USA processes and verifies a doctor's prescription before sourcing, procuring and shipping the medicine.
How are temperature-sensitive medicines shipped to patients?
Medicines ship through a WHO GDP-certified, validated cold-chain where required, with internal quality assurance before dispatch.
How do I request a medicine for a patient?
Patients, caregivers or physicians can submit the prescription through our online form, and GNH USA will respond with availability and timing.
Related
Other services
Comparator Sourcing for Clinical Trials
Reference-listed drug and active comparator supply for clinical trials worldwide — direct from manufacturer, with WHO GDP-compliant logistics.
Clinical Trials Supply
End-to-end IMP sourcing, kitting and depot-to-site logistics — GDP-compliant warehousing, manufacturer relationships and a full source-to-site audit trail.
Validated Cold Chain Shipment
WHO GDP-validated cold-chain shipping for biologics, vaccines and temperature-sensitive medicines — qualified boxes and en-route temperature monitoring.